Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-06 Mayo Stephen Director Grant or award +1,523 7,910
2023-03-06 Mayo Stephen Director Grant or award · Stock Option (right to buy) +3,257 3,257
2023-03-01 Arif Bilal Chief Tech Ops Officer Shares withheld for taxes −80 $147.57 $12K 22,837
2023-03-01 Arif Bilal Chief Tech Ops Officer Shares withheld for taxes −172 $147.57 $25K 22,828
2023-03-01 Brown Ryan Edward SVP, General Counsel Shares withheld for taxes −196 $147.57 $29K 25,645
2023-03-01 Estepan Ian Michael Chief Financial Officer Shares withheld for taxes −378 $147.57 $56K 32,293
2023-03-01 Rodino-Klapac Louise Head of R&D, CSO Shares withheld for taxes −522 $147.57 $77K 67,716
2022-12-31 Arif Bilal Chief Tech Ops Officer Grant or award · Stock Option (right to buy) +30,000 30,000
2022-12-19 BEHRENS M KATHLEEN Director Exercise or conversion +20,000 $34.92 $698K 158,470
2022-12-19 BEHRENS M KATHLEEN Director Exercise or conversion · Stock Option (Right to Buy) −20,000 0
2022-11-17 Rodino-Klapac Louise Head of R&D, CSO Shares withheld for taxes −4,211 $108.52 $457K 67,998
2022-11-17 Mayo Stephen Director Sale −858 $109.92 $94K 6,387
2022-09-14 Chambers Michael Andrew Director Purchase +20,744 $103.87 $2.2M 71,822
2022-09-14 Chambers Michael Andrew Director Purchase +30,106 $104.67 $3.2M 101,928
2022-09-14 Chambers Michael Andrew Director Purchase +6,250 $105.16 $657K 108,178
2022-09-13 Chambers Michael Andrew Director Grant or award · Convertible Senior Notes +0 $20,000,000.00 $0
2022-08-19 Chambers Michael Andrew Director Purchase +40,110 $108.20 $4.3M 45,018
2022-08-19 Chambers Michael Andrew Director Purchase +6,060 $108.80 $659K 51,078
2022-06-02 Boor Kathryn Jean Director Grant or award +4,908 4,908
2022-06-02 Boor Kathryn Jean Director Grant or award · Stock Option (right to buy) +8,329 8,329

Page 17 of 22 · 424 trades